Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2487 (LINC02487)

Target
LINC02487
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2487 (LINC02487) is a long non-coding RNA (lncRNA) that functions as a tumor suppressor in several human cancers, including oral squamous cell carcinoma and cervical cancer. LINC02487 is generally downregulated in tumor tissues, with its expression inversely linked to cancer cell proliferation, migration, and invasion. Mechanistically, it acts through key cancer-related pathways; for example, in cervical cancer it upregulates phosphatase and tensin homolog (PTEN) and inhibits the Akt/mTOR signaling pathway, and in oral squamous cell carcinoma it directly binds USP17 and affects the USP17–SNAI1 axis, modulating EMT and metastasis. Its potential clinical utility is as a biomarker for cancer presence or metastasis, and possibly as a future RNA-based therapeutic target. LINC02487 is classified as a long non-coding RNA, and not as a receptor, enzyme, or traditional drug target; it exerts regulatory control via interactions with protein-coding genes and mediator proteins.

Other names
LINC02487long non-coding RNA LINC02487lncRNA LINC02487
02

Mechanism of action

Not applicable; LINC02487 is a non-protein-coding RNA and is not directly targeted by drugs, but regulates other targets (e.g., PTEN, USP17) that could be therapeutically relevant

03

Biological functions

Tumor suppressor activityRegulation of cell proliferationInhibition of cell migration and invasionRegulation of epithelial–mesenchymal transition (EMT)Regulation of signaling pathways (e.g., Akt/mTOR, PTEN, USP17–SNAI1 axis)
04

Disease associations

Cancer (notably oral squamous cell carcinoma, cervical cancer, head and neck cancer, triple-negative breast cancer)Potential biomarker for cancer metastasis and progression
05

Safety considerations

No specific safety concerns described; as a target, modulation would require advanced RNA-targeting therapeutics
06

Biomarkers

LINC02487 expression (potential biomarker for certain cancers/metastasis)Possible downstream proteins: PTEN, EMT markers (E-cadherin, N-cadherin, vimentin), SNAI1, USP17

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2487 (LINC02487).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2487 (LINC02487).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call